Navigation Links
Medifast, Inc. Receives Approval to Sell Medifast Weight Control Centers Franchises in Seven Additional States
Date:12/17/2007

OWINGS MILLS, Md., Dec. 17 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) today announced that the Company has received approval to sell Medifast Weight Control Centers franchises in seven additional states, making the franchise opportunity available in 43 states. Medifast recently received approval to sell franchises in California, Illinois, Maryland, Minnesota, New York, Rhode Island and Virginia.

"The Medifast Weight Control Centers model is supported by an umbrella of brand awareness from our national advertising program. The Centers offer a unique service to individuals looking for a more regimented and supported approach to losing weight," says Michael S. McDevitt, Chief Executive Officer. "We believe this latest development in our business presents an exciting opportunity for the future growth of the Medifast Weight Control Centers division."

The Medifast Weight Control Centers program offers structured weight loss and maintenance phases to help patients safely and effectively lose weight and change their eating habits and lifestyle long-term. Patients can expect to lose between 2-5 pounds per week for about $7 per visit, based upon the purchase of a complete full service program plus the cost of Medifast Meals.

"Medifast Weight Control Centers offers guaranteed results through personal one-on-one support with certified counselors and a medical review, and the latest in fast, safe weight loss," says Joe DiBartolomeo, Ph.D., Senior Vice President of Medifast Weight Control Centers. "Our exclusive Forever Slim Program tailors plans to meet the individual's needs, which helps our patients achieve their weight loss goals."

Jason Properties, LLC, a division of Medifast, now operates 10 corporate- owned Medifast Weight Control Centers in Texas and Florida. The Company plans to open an additional 25-30 corporate-owned Centers over the next two years in selected markets.

For more information on this business opportunity, please visit http://www.MedifastCenters.com.

Franchisee Requests:

Dr. Joe DiBartolomeo

Senior Vice President

Medifast Weight Control Centers

410-504-8170

jdibartolomeo@MedifastCenters.com

About Medifast:

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by 15,000 physicians and used by over one million customers. It is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) national network of physicians, 3) medically supervised Medifast Weight Control Centers and 4) the Take Shape For Life direct-selling division, a network of health coaches. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto http://www.ChooseMedifast.com.

Media Requests:

Brian Gleason

Public Relations Manager

Medifast, Inc.

410-502-8260

bgleason@ChooseMedifast.com


'/>"/>
SOURCE Medifast, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medifast, Inc. Announces Support for Microsoft HealthVault
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
10. Prime Therapeutics Receives TIPPS Certification
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Linda, Ca (PRWEB) , ... January 19, 2017 ... ... virtual events for tech innovators, engineers, and scientists from around the world, announces ... site offers users a quick and easy portal to research breakthroughs and trending ...
(Date:1/19/2017)... Utah (PRWEB) , ... January 19, 2017 , ... ... Festival in a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew Petersen and ... provide a condensed version of the clinic’s leading recovery program. , “We ...
(Date:1/19/2017)... ... 2017 , ... Bio-Optronics Inc. is proud to announce the ... to seamlessly integrate and streamline the way researchers prepare and conduct patient visits. ... and improving efficiency significantly for users – a first in the CTMS industry. ...
(Date:1/19/2017)... ... 19, 2017 , ... Workrite Ergonomics announced this week the ... privacy panel system was designed to deliver the ideal blend of acoustic and ... provide the visual privacy required to maintain concentration levels and increase productivity. The ...
(Date:1/19/2017)... ... January 19, 2017 , ... Rountree Brady Insurance Agency, ... communities throughout eastern Georgia, is embarking on a charity effort to raise awareness ... more Americans every year than anything else, yet risk factors associated with heart ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Jan. 19, 2017 The Global Therapy Partnering ... access to partnering deals and agreements entered into by ... partnering deals - Top deals by value - Deals ... technology type The report provides understanding and access ... the world,s leading healthcare companies. The report provides ...
(Date:1/19/2017)... 2017 Report Details ... Alzheimer,s Disease Therapeutics ... – our new study reveals trends, R&D progress, and ... affecting the Alzheimer,s disease therapeutics and diagnostics market. Our ... questions: - How is the Alzheimer,s disease therapeutics and ...
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ( ... treat mitochondrial dysfunction, today announced new additions to its ... as Chief Medical Officer, and Daniel Geffken ... that Jim Carr , Pharm.D. has been promoted ... are pleased to welcome Doug and Daniel to our ...
Breaking Medicine Technology: